Roy M. Pollock

11.6k citations
56 papers · 6.4k · 5 hit papers · h-index 29

Impact in

  • Hematology top 1%
    • Acute Myeloid Leukemia Research
    • Epigenetics and DNA Methylation
    • Cancer-related gene regulation
    • Protein Degradation and Inhibitors
    • Histone Deacetylase Inhibitors Research
    • Genomics and Chromatin Dynamics
    • RNA modifications and cancer
    • RNA Research and Splicing

Papers in

    • Epigenetics and DNA Methylation 23
    • Cancer-related gene regulation 21
    • Ubiquitin and proteasome pathways 8
    • Protein Degradation and Inhibitors 7
    • RNA Interference and Gene Delivery 4
    • Histone Deacetylase Inhibitors Research 4
    • Acute Myeloid Leukemia Research 15
    • Multiple Myeloma Research and Treatments 5

Roy M. Pollock

56 papers receiving 6.2k citations

Roy M. Pollock's Hit Papers

Potent inhibition of DOT1L as treatment of MLL-fusion leukemia 2013 · 550 citations
5500+12+25Years since publication250500750

Peers

Roy M. Pollock
Comparison fields: 5 of 117
  • Hematology 915
  • Molecular Biology 5.3k
  • Genetics 729
  • Cancer Research 335
  • Oncology 595
Replace Beric R. Henderson with:
Beric R. Henderson Australia
Robert J. Sims United States
Rosa Bernardi Italy
Junwei Shi United States
Xiaobing Shi United States
Kurtis E. Bachman United States
W. Todd Miller United States
Alessandro Vindigni United States
Dalia Baršytė-Lovejoy Canada
Patrick Trojer United States
Roy M. Pollock relative to Beric R. Henderson Australia Beric R. Henderson's profile →
Citations per field
00.5×2.8×
Beric R. Henderson · 1×
Citations per year

Countries citing papers authored by Roy M. Pollock

Since Specialization
Citations

This map shows the geographic impact of Roy M. Pollock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy M. Pollock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy M. Pollock more than expected).

Fields of papers citing papers by Roy M. Pollock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy M. Pollock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy M. Pollock. The network helps show where Roy M. Pollock may publish in the future.

Co-authors

The 25 scholars most cited alongside Roy M. Pollock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roy M. Pollock Line = papers co-authored together Roy M. Pollock links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element
Hit paper breakdown →
1988883
2
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
Hit paper breakdown →
2011646
3
Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
Hit paper breakdown →
2013589
4
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
Hit paper breakdown →
2013550
5
Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas
Hit paper breakdown →
2010503
6 1996437
7 1991392
8 1990308
9 1997182
10 2004152
11 2013132
12 2016129
13 2012116
14 2015107
15 2012103
16 1996101
17 201499
18 200090
19 201188
20 200282

About Roy M. Pollock

Roy M. Pollock is a scholar working on Molecular Biology, Hematology, Oncology, Pathology and Forensic Medicine and Genetics, having authored 56 papers that have together received 6.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (23 papers), Cancer-related gene regulation (21 papers), Acute Myeloid Leukemia Research (15 papers), Ubiquitin and proteasome pathways (8 papers), Protein Degradation and Inhibitors (7 papers), Multiple Myeloma Research and Treatments (5 papers), RNA Interference and Gene Delivery (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Hematology (915 citations), Molecular Biology (5.3k citations), Genetics (729 citations), Cancer Research (335 citations) and Oncology (595 citations). Roy M. Pollock has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Richard Treisman, Victoria M. Richon, Christine M. Norman, M J Runswick, Robert A. Copeland, Margaret Porter Scott, Kevin W. Kuntz, Tim Clackson, Sarah K. Knutson and Mikel P. Moyer. Their work appears in journals such as Blood, Proceedings of the National Academy of Sciences, PLoS ONE, Cancer Research and Hematological Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact